Organon & Co banner

Organon & Co
NYSE:OGN

Watchlist Manager
Organon & Co Logo
Organon & Co
NYSE:OGN
Watchlist
Price: 13.29 USD 0.3% Market Closed
Market Cap: $3.5B

Revenue Breakdown

Breakdown by Geography
Organon & Co

Total Revenue: 6.2B USD
100%
Int’l: 4.8B USD
77.7%
Europe And Canada: 1.8B USD
28.4%
United States: 1.6B USD
25.3%
Asia Pacific And Japan: 1.1B USD
16.9%
Latin America, Middle East, Russia, And Africa: 1B USD
16.6%
China: 847m USD
13.6%
Other: 137m USD
2.2%
Show More
Show Less

Breakdown by Segments
Organon & Co

Total Revenue: 6.2B USD
100%
Nexplanon/Implanon Nxt: 963m USD
15.5%
Atozet: 473m USD
7.6%
Singulair: 359m USD
5.8%
Zetia: 317m USD
5.1%
Other Non-Opiod Pain, Bone And Dermatology: 295m USD
4.7%
Nasonex: 276m USD
4.4%
Renflexis: 274m USD
4.4%
Arcoxia: 270m USD
4.3%
Cozaar/Hyzaar: 243m USD
3.9%
Follistim Aq: 237m USD
3.8%
Dulera: 203m USD
3.3%
Other Women's Health: 158m USD
2.5%
Fosamax: 151m USD
2.4%
Hadlima: 142m USD
2.3%
Ontruzant: 141m USD
2.3%
Diprospan: 139m USD
2.2%
Marvelon/Mercilon: 134m USD
2.2%
Other Cardiovascular: 133m USD
2.1%
Clarinex: 127m USD
2%
Nuvaring: 115m USD
1.9%
Propecia: 111m USD
1.8%
Ganirelix Acetate Injection: 109m USD
1.8%
Vytorin: 108m USD
1.7%
Emgality/Rayvow: 107m USD
1.7%
Proscar: 95m USD
1.5%
Brenzys: 77m USD
1.2%
Jada: 61m USD
1%
Other Respiratory: 53m USD
0.9%
Rosuzet: 49m USD
0.8%
Aybintio: 28m USD
0.5%
Vtama: 12m USD
0.2%
Show More
Show Less
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett